Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is N and Author is Nakasone, Hideki  [Clear All Filters]
Journal Article
Nakano, H., Ashizawa, M., Akahoshi, Y., Ugai, T., Wada, H., Yamasaki, R., Ishihara, Y., Kawamura, K., Sakamoto, K., Sato, M., et al. (2016). Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.Int J Hematol.
Inamoto, Y., Kimura, F., Kanda, J., Sugita, J., Ikegame, K., Nakasone, H., Nannya, Y., Uchida, N., Fukuda, T., Yoshioka, K., et al. (2016). Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Haematologica.
Akahoshi, Y., Nakasone, H., Kawamura, K., Kusuda, M., Kawamura, S., Takeshita, J., Yoshino, N., Misaki, Y., Yoshimura, K., Gomyo, A., et al. (2020). Detection of T315I using digital PCR in allogeneic transplant recipients with Ph-positive ALL in the dasatinib era.Exp Hematol.
Akahoshi, Y., Nakasone, H., Kawamura, K., Kusuda, M., Kawamura, S., Takeshita, J., Yoshino, N., Misaki, Y., Yoshimura, K., Gomyo, A., et al. (2019). Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.Blood Adv3, 3287-3296.
Nakasone, H., Sahaf, B., Tian, L., Wang, T., Haagenson, M.D., Schoenrock, K., Perloff, S., Ryan, C.E., Wu, F., Spellman, S.R., et al. (2015). Pre-sensitization to HY-antigens in female donors prior to transplant is not associated with male recipient post-transplant HY-antibody development nor clinical outcomes.Haematologica.
Ohwada, C., Sakaida, E., Igarashi, A., Kobayashi, T., Doki, N., Mori, T., Kato, J., Koda, Y., Kanamori, H., Tanaka, M., et al. (2019). A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.Biol Blood Marrow Transplant.
Kimura, S.-I., Sato, M., Misaki, Y., Yoshimura, K., Gomyo, A., Hayakawa, J., Akahoshi, Y., Harada, N., Tamaki, M., Kusuda, M., et al. (2019). Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation.Transpl Immunol101262.
Akahoshi, Y., Kanda, J., Gomyo, A., Hayakawa, J., Komiya, Y., Harada, N., Kameda, K., Ugai, T., Wada, H., Ishihara, Y., et al. (2016). Risk Factors and Impact of Secondary Failure of Platelet Recovery after Allogeneic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Ashizawa, M., Akahoshi, Y., Nakano, H., Kawamura, S., Takeshita, J., Yoshino, N., Misaki, Y., Yoshimura, K., Gomyo, A., Tamaki, M., et al. (2019). Updated clinical outcomes of hematopoietic stem cell transplantation using myeloablative total body irradiation with ovarian shielding to preserve fertility.Biol Blood Marrow Transplant.